Lysosomal Storage Disorders and Iron

International Review of Neurobiology

Volumn 110, Issue , 2013, Pages 251-275

  Bras, Jose Miguel ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Iron; Lysosomal storage disorders; Lysosome; Neuronal ceroid lipofuscinosis; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE 13A2; DIPEPTIDYL PEPTIDASE; IRON; LIPOFUSCIN; MANNOSE 6 PHOSPHORYLATED TPP1; MEMBRANE PROTEIN; PALMITOYL PROTEIN THIOESTERASE; PROGRANULIN; PROTEIN CLN3; PROTEIN CLN5; PROTEIN CLN6; UNCLASSIFIED DRUG;

ARTICLE; CELL COMPARTMENTALIZATION; CELL FUNCTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FRONTOTEMPORAL DEMENTIA; GAUCHER DISEASE; GBA GENE; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; IRON BALANCE; IRON METABOLISM; IRON TRANSPORT; LYSOSOME; LYSOSOME STORAGE DISEASE; MOLECULAR PATHOLOGY; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

ALZHEIMER'S DISEASE; IRON; LYSOSOMAL STORAGE DISORDERS; LYSOSOME; NEURONAL CEROID LIPOFUSCINOSIS; PARKINSON'S DISEASE;

HOMEOSTASIS; HUMANS; IRON; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; NEURODEGENERATIVE DISEASES;

EID: 84887261234     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-410502-7.00012-0     Document Type: Chapter

References (114)

1. Ahmed Z., Sheng H., Xu Y.F., Lin W.L., Innes A.E., Gass J., et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. The American Journal of Pathology 2010, 177(1):311-324. (Research Support, Non-U.S. Gov't).
2. Aisen P., Leibman A., Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin. The Journal of Biological Chemistry 1978, 253(6):1930-1937. (Research Support, U.S. Gov't, P.H.S.).
3. Almeida S., Zhou L., Gao F.B. Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins. PLoS One 2011, 6(10):e26454. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
4. Anderson G.J., Vulpe C.D. Mammalian iron transport. Cellular and Molecular Life Sciences 2009, 66(20):3241-3261. (Review).
5. Arosio P., Ingrassia R., Cavadini P. Ferritins: A family of molecules for iron storage, antioxidation and more. Biochimica et Biophysica Acta 2009, 1790(7):589-599. (Research Support, Non-U.S. Gov't Review).
6. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442(7105):916-919. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
7. Balla J., Jacob H.S., Balla G., Nath K., Eaton J.W., Vercellotti G.M. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(20):9285-9289. (In Vitro Research Support, U.S. Gov't, P.H.S.).
8. Balla G., Jacob H.S., Balla J., Rosenberg M., Nath K., Apple F., et al. Ferritin: A cytoprotective antioxidant strategem of endothelium. The Journal of Biological Chemistry 1992, 267(25):18148-18153. (Research Support, U.S. Gov't, P.H.S.).
9. Barton J.C. Handbook of iron overload disorders 2010, Cambridge University Press, Cambridge; New york, ix, 376 p.
10. Beutler E. Gaucher disease. Blood Reviews 1988, 2(1):59-70. (Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review).
11. Beutler E. Gaucher disease: Multiple lessons from a single gene disorder. Acta Paediatrica 2006, 95(451):103-109. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review).
12. Bras J., Paisan-Ruiz C., Guerreiro R., Ribeiro M.H., Morgadinho A., Januario C., et al. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiology of Aging 2009, 30(9):1515-1517.
13. Bras J., Singleton A., Cookson M.R., Hardy J. Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease. The FEBS Journal 2008, 275(23):5767-5773.
14. Bras J., Verloes A., Schneider S.A., Mole S.E., Guerreiro R.J. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Human Molecular Genetics 2012, 21(12):2646-2650. (Research Support, Non-U.S. Gov't).
15. Bright N.A., Gratian M.J., Luzio J.P. Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Current Biology 2005, 15(4):360-365. (Comparative Study Research Support, Non-U.S. Gov't).
16. Brissot P., Bardou-Jacquet E., Jouanolle A.M., Loreal O. Iron disorders of genetic origin: A changing world. Trends in Molecular Medicine 2011, 17(12):707-713. (Research Support, Non-U.S. Gov't Review).
17. Brunk U., Ericsson J.L. Electron microscopical studies on rat brain neurons. Localization of acid phosphatase and mode of formation of lipofuscin bodies. Journal of Ultrastructure Research 1972, 38(1):1-15.
18. Brunk U.T., Neuzil J., Eaton J.W. Lysosomal involvement in apoptosis. Redox Report: Communications in Free Radical Research 2001, 6(2):91-97. (Review).
19. Brunk U.T., Terman A. Lipofuscin: Mechanisms of age-related accumulation and influence on cell function. Free Radical Biology & Medicine 2002, 33(5):611-619. (Research Support, Non-U.S. Gov't Review).
20. Brunk U.T., Terman A. The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. European Journal of Biochemistry / FEBS 2002, 269(8):1996-2002. (Research Support, Non-U.S. Gov't Review).
21. Cao Y., Staropoli J.F., Biswas S., Espinola J.A., MacDonald M.E., Lee J.M., et al. Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells. PLoS One 2011, 6(2):e17118. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
22. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442(7105):920-924. (Research Support, Non-U.S. Gov't).
23. Das A.K., Becerra C.H., Yi W., Lu J.Y., Siakotos A.N., Wisniewski K.E., et al. Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. The Journal of Clinical Investigation 1998, 102(2):361-370. (Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.).
24. De Domenico I., McVey Ward D., Kaplan J. Regulation of iron acquisition and storage: Consequences for iron-linked disorders. Nature Reviews. Molecular Cell Biology 2008, 9(1):72-81. (Research Support, N.I.H., Extramural Review).
25. de Duve C. The lysosome turns fifty. Nature Cell Biology 2005, 7(9):847-849. (Historical Article).
26. Dehay B., Ramirez A., Martinez-Vicente M., Perier C., Canron M.H., Doudnikoff E., et al. Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(24):9611-9616. (Research Support, Non-U.S. Gov't).
27. Desjardins M. Biogenesis of phagolysosomes: The 'kiss and run' hypothesis. Trends in Cell Biology 1995, 5(5):183-186.
28. Dunn L.L., Suryo Rahmanto Y., Richardson D.R. Iron uptake and metabolism in the new millennium. Trends in Cell Biology 2007, 17(2):93-100. (Research Support, Non-U.S. Gov't Review).
29. Durr A., Hahn-Barma V., Brice A., Pecheux C., Dode C., Feingold J. Homozygosity in Huntington's disease. Journal of Medical Genetics 1999, 36(2):172-173. (Case Reports Letter).
30. Eskelinen E.L., Tanaka Y., Saftig P. At the acidic edge: Emerging functions for lysosomal membrane proteins. Trends in Cell Biology 2003, 13(3):137-145. (Research Support, Non-U.S. Gov't Review).
31. Gabizon R., Rosenmann H., Meiner Z., Kahana I., Kahana E., Shugart Y., et al. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). American Journal of Human Genetics 1993, 53(4):828-835. (Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.).
32. Galy B., Ferring D., Benesova M., Benes V., Hentze M.W. Targeted mutagenesis of the murine IRP1 and IRP2 genes reveals context-dependent RNA processing differences in vivo. RNA 2004, 10(7):1019-1025. (Research Support, Non-U.S. Gov't).
33. Germain D.P. Gaucher's disease: A paradigm for interventional genetics. Clinical Genetics 2004, 65(2):77-86. (Review).
34. Guerreiro R.J., Lohmann E., Bras J.M., Gibbs J.R., Rohrer J.D., Gurunlian N., et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. Archives of Neurology 2012, 1-7.
35. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., et al. TREM2 variants in Alzheimer's disease. The New England Journal of Medicine 2013, 368(2):117-127. (Meta-Analysis Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't).
36. Haglund K., Sigismund S., Polo S., Szymkiewicz I., Di Fiore P.P., Dikic I. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nature Cell Biology 2003, 5(5):461-466. (Research Support, Non-U.S. Gov't).
37. Hardy J., Lewis P., Revesz T., Lees A., Paisan-Ruiz C. The genetics of Parkinson's syndromes: A critical review. Current Opinion in Genetics & Development 2009, 19(3):254-265. (Review).
38. He Z., Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. Journal of Molecular Medicine 2003, 81(10):600-612. (Research Support, Non-U.S. Gov't Review).
39. Helenius A., Mellman I., Wall D., Hubbard A. Endosomes. Trends in Biochemical Sciences 1983, 8(7):245-250.
40. Holopainen J.M., Saarikoski J., Kinnunen P.K., Jarvela I. Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). European Journal of Biochemistry / FEBS 2001, 268(22):5851-5856. (Research Support, Non-U.S. Gov't).
41. Horowitz M., Wilder S., Horowitz Z., Reiner O., Gelbart T., Beutler E. The human glucocerebrosidase gene and pseudogene: Structure and evolution. Genomics 1989, 4(1):87-96. (Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.).
42. Hruska K.S., LaMarca M.E., Scott C.R., Sidransky E. Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Human Mutation 2008, 29(5):567-583. (Review).
43. Hu F., Padukkavidana T., Vaegter C.B., Brady O.A., Zheng Y., Mackenzie I.R., et al. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 2010, 68(4):654-667. (Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
44. Huang F., Kirkpatrick D., Jiang X., Gygi S., Sorkin A. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Molecular Cell 2006, 21(6):737-748. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
45. Iancu T., Shiloh H. Morphologic observations in iron overload: An update. Progress in iron research 1994, Vol. 356:255-265. Springer, US. C. Hershko, A. Konijn, P. Aisen (Eds.).
46. Isolation of a novel gene underlying Batten disease, CLN3. The International Batten disease consortium. Cell 1995, 82(6):949-957. (Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.).
47. Jarvela I., Lehtovirta M., Tikkanen R., Kyttala A., Jalanko A. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Human Molecular Genetics 1999, 8(6):1091-1098. (Research Support, Non-U.S. Gov't).
48. Johansson E., Lindh U., Westermarck T., Heiskala H., Santavuori P. Altered elemental profiles in neuronal ceroid lipofuscinosis. Journal of Trace Elements and Electrolytes in Health and Disease 1990, 4(3):139-142. (Research Support, Non-U.S. Gov't).
49. Jolly R.D., Douglas B.V., Davey P.M., Roiri J.E. Lipofuscin in bovine muscle and brain: A model for studying age pigment. Gerontology 1995, 41(Suppl. 2):283-295. (Research Support, U.S. Gov't, P.H.S.).
50. Journet A., Chapel A., Kieffer S., Roux F., Garin J. Proteomic analysis of human lysosomes: Application to monocytic and breast cancer cells. Proteomics 2002, 2(8):1026-1040. (Research Support, Non-U.S. Gov't).
51. Junaid M.A., Pullarkat R.K. Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases. Neuroscience Letters 1999, 264(1-3):157-160. (Research Support, U.S. Gov't, P.H.S.).
52. Katzin L.W., Amato A.A. Pompe disease: A review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. Journal of Clinical Neuromuscular Disease 2008, 9(4):421-431. (Review).
53. Klionsky D.J. Autophagy: From phenomenology to molecular understanding in less than a decade. Nature Reviews. Molecular Cell Biology 2007, 8(11):931-937. (Research Support, N.I.H., Extramural Review).
54. Kominami A.E. What are the requirements for lysosomal degradation of subunit c of mitochondrial ATPase?. IUBMB Life 2002, 54(2):89-90.
55. Kurz T., Eaton J.W., Brunk U.T. Redox activity within the lysosomal compartment: Implications for aging and apoptosis. Antioxidants & Redox Signaling 2010, 13(4):511-523. (Review).
56. Kurz T., Terman A., Gustafsson B., Brunk U.T. Lysosomes and oxidative stress in aging and apoptosis. Biochimica et Biophysica Acta 2008, 1780(11):1291-1303. (Review).
57. Kyttala A., Lahtinen U., Braulke T., Hofmann S.L. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins. Biochimica et Biophysica Acta 2006, 1762(10):920-933. (Review).
58. Lerer I., Merims D., Abeliovich D., Zlotogora J., Gadoth N. Machado-Joseph disease: Correlation between the clinical features, the CAG repeat length and homozygosity for the mutation. European Journal of Human Genetics 1996, 4(1):3-7.
59. Levine B., Klionsky D.J. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Developmental Cell 2004, 6(4):463-477. (Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review).
60. Levy J.E., Jin O., Fujiwara Y., Kuo F., Andrews N.C. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nature Genetics 1999, 21(4):396-399. (Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.).
61. Luzio J.P., Pryor P.R., Bright N.A. Lysosomes: Fusion and function. Nature Reviews. Molecular Cell Biology 2007, 8(8):622-632. (Research Support, Non-U.S. Gov't Review).
62. Machaczka M., Rucinska M., Skotnicki A.B., Jurczak W. Parkinson's syndrome preceding clinical manifestation of Gaucher's disease. American Journal of Hematology 1999, 61(3):216-217. (Case Reports Letter).
63. Matsumura R., Futamura N., Fujimoto Y., Yanagimoto S., Horikawa H., Suzumura A., et al. Spinocerebellar ataxia type 6. Molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion. Neurology 1997, 49(5):1238-1243. (Research Support, Non-U.S. Gov't).
64. McNeil P.L., Kirchhausen T. An emergency response team for membrane repair. Nature Reviews. Molecular Cell Biology 2005, 6(6):499-505. (Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review).
65. Mekinian A., Stirnemann J., Belmatoug N., Heraoui D., Fantin B., Fain O., et al. Ferritinemia during type 1 Gaucher disease: Mechanisms and progression under treatment. Blood Cells, Molecules & Diseases 2012, 49(1):53-57. (Research Support, Non-U.S. Gov't).
66. Mellman I. Endocytosis and molecular sorting. Annual Review of Cell and Developmental Biology 1996, 12:575-625. (Review).
67. Mellman I., Fuchs R., Helenius A. Acidification of the endocytic and exocytic pathways. Annual Review of Biochemistry 1986, 55:663-700. (Review).
68. Morgan N.V., Westaway S.K., Morton J.E., Gregory A., Gissen P., Sonek S., et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nature Genetics 2006, 38(7):752-754. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
69. Mukherjee S., Ghosh R.N., Maxfield F.R. Endocytosis. Physiological Reviews 1997, 77(3):759-803. (Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review).
70. Munoz M., Villar I., Garcia-Erce J.A. An update on iron physiology. World Journal of Gastroenterology 2009, 15(37):4617-4626. (Review).
71. Nakagawa I., Amano A., Mizushima N., Yamamoto A., Yamaguchi H., Kamimoto T., et al. Autophagy defends cells against invading group a streptococcus. Science 2004, 306(5698):1037-1040. (Research Support, Non-U.S. Gov't).
72. Narayan S.B., Rakheja D., Tan L., Pastor J.V., Bennett M.J. CLN3P, the Batten's disease protein, is a novel palmitoyl-protein Delta-9 desaturase. Annals of Neurology 2006, 60(5):570-577.
73. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annual Review of Nutrition 2006, 26:323-342. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review).
74. Neudorfer O., Giladi N., Elstein D., Abrahamov A., Turezkite T., Aghai E., et al. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM: Monthly Journal of the Association of Physicians 1996, 89(9):691-694. (Research Support, Non-U.S. Gov't).
75. Neumann J., Bras J., Deas E., O'Sullivan S.S., Parkkinen L., Lachmann R.H., et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009, 132(Pt 7):1783-1794.
76. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005, 365(9457):410-412. (Multicenter Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.).
77. Nixon R.A., Yang D.S., Lee J.H. Neurodegenerative lysosomal disorders: A continuum from development to late age. Autophagy 2008, 4(5):590-599. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review).
78. Paisan-Ruiz C., Bhatia K.P., Li A., Hernandez D., Davis M., Wood N.W., et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Annals of Neurology 2009, 65(1):19-23. (Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't).
79. Palmer D.N., Fearnley I.M., Walker J.E., Hall N.A., Lake B.D., Wolfe L.S., et al. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). American Journal of Medical Genetics 1992, 42(4):561-567. (Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.).
80. Palmer D.N., Jolly R.D., van Mil H.C., Tyynela J., Westlake V.J. Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease). Neuropediatrics 1997, 28(1):45-48. (Research Support, U.S. Gov't, P.H.S.).
81. Paloneva J., Manninen T., Christman G., Hovanes K., Mandelin J., Adolfsson R., et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. American Journal of Human Genetics 2002, 71(3):656-662. (Research Support, Non-U.S. Gov't).
82. Peters T.J., Seymour C.A. Acid hydrolase activities and lysosomal integrity in liver biopsies from patients with iron overload. Clinical Science and Molecular Medicine 1976, 50(1):75-78.
83. Pryor P.R., Mullock B.M., Bright N.A., Gray S.R., Luzio J.P. The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. The Journal of Cell Biology 2000, 149(5):1053-1062. (Research Support, Non-U.S. Gov't).
84. Ramirez A., Heimbach A., Grundemann J., Stiller B., Hampshire D., Cid L.P., et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nature Genetics 2006, 38(10):1184-1191. (Research Support, Non-U.S. Gov't).
85. Ramirez-Montealegre D., Pearce D.A. Defective lysosomal arginine transport in juvenile Batten disease. Human Molecular Genetics 2005, 14(23):3759-3773. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
86. Richardson D.R., Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochimica et Biophysica Acta 1997, 1331(1):1-40. (Research Support, Non-U.S. Gov't Review).
87. Rodriguez A., Webster P., Ortego J., Andrews N.W. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. The Journal of Cell Biology 1997, 137(1):93-104. (Research Support, U.S. Gov't, P.H.S.).
88. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nature Chemical Biology 2006, 2(8):406-414. (Research Support, N.I.H., Intramural Review).
89. Ryan C.L., Baranowski D.C., Chitramuthu B.P., Malik S., Li Z., Cao M., et al. Progranulin is expressed within motor neurons and promotes neuronal cell survival. BMC Neuroscience 2009, 10:130. (Research Support, Non-U.S. Gov't).
90. Sanpei K., Takano H., Igarashi S., Sato T., Oyake M., Sasaki H., et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genetics 1996, 14(3):277-284. (Research Support, Non-U.S. Gov't).
91. Schulz A., Mousallem T., Venkataramani M., Persaud-Sawin D.A., Zucker A., Luberto C., et al. The CLN9 protein, a regulator of dihydroceramide synthase. The Journal of Biological Chemistry 2006, 281(5):2784-2794. (Research Support, Non-U.S. Gov't).
92. Scriver C.R. The metabolic and molecular bases of inherited disease 1995, McGraw-Hill, Health Professions Division, New York. 7th ed.
93. Seehafer S.S., Pearce D.A. You say lipofuscin, we say ceroid: Defining autofluorescent storage material. Neurobiology of Aging 2006, 27(4):576-588. (Research Support, N.I.H., Extramural Review).
94. Selden C., Owen M., Hopkins J.M., Peters T.J. Studies on the concentration and intracellular localization of iron proteins in liver biopsy specimens from patients with iron overload with special reference to their role in lysosomal disruption. British Journal of Haematology 1980, 44(4):593-603.
95. Seymour C.A., Peters T.J. Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes. British Journal of Haematology 1978, 40(2):239-253.
96. Shapiro B.E., Logigian E.L., Kolodny E.H., Pastores G.M. Late-onset Tay-Sachs disease: The spectrum of peripheral neuropathy in 30 affected patients. Muscle & Nerve 2008, 38(2):1012-1015.
97. Sharp P., Srai S.K. Molecular mechanisms involved in intestinal iron absorption. World Journal of Gastroenterology 2007, 13(35):4716-4724. (Research Support, Non-U.S. Gov't Review).
98. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. The New England Journal of Medicine 2009, 361(17):1651-1661.
99. Siintola E., Partanen S., Stromme P., Haapanen A., Haltia M., Maehlen J., et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain: A Journal of Neurology 2006, 129(Pt 6):1438-1445. (Case Reports Research Support, Non-U.S. Gov't).
100. Smith K.R., Damiano J., Franceschetti S., Carpenter S., Canafoglia L., Morbin M., et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. American Journal of Human Genetics 2012, 90(6):1102-1107. (Research Support, Non-U.S. Gov't).
101. Sobue G., Doyu M., Nakao N., Shimada N., Mitsuma T., Maruyama H., et al. Homozygosity for Machado-Joseph disease gene enhances phenotypic severity. Journal of Neurology, Neurosurgery, and Psychiatry 1996, 60(3):354-356. (Case Reports Letter).
102. Spada M., Pagliardini S., Yasuda M., Tukel T., Thiagarajan G., Sakuraba H., et al. High incidence of later-onset fabry disease revealed by newborn screening. American Journal of Human Genetics 2006, 79(1):31-40. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
103. Staropoli J.F., Karaa A., Lim E.T., Kirby A., Elbalalesy N., Romansky S.G., et al. A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system. American Journal of Human Genetics 2012, 91(1):202-208. (Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't).
104. Takahashi K., Prinz M., Stagi M., Chechneva O., Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Medicine 2007, 4(4):e124. (Research Support, Non-U.S. Gov't).
105. Tang J., Kriz R.W., Wolfman N., Shaffer M., Seehra J., Jones S.S. A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. The Journal of Biological Chemistry 1997, 272(13):8567-8575.
106. Terman A., Gustafsson B., Brunk U.T. Autophagy, organelles and ageing. The Journal of Pathology 2007, 211(2):134-143. (Review).
107. Van Bogaert P., Azizieh R., Desir J., Aeby A., De Meirleir L., Laes J.F., et al. Mutation of a potassium channel-related gene in progressive myoclonic epilepsy. Annals of Neurology 2007, 61(6):579-586. (Research Support, Non-U.S. Gov't).
108. van Swieten J.C., Heutink P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurology 2008, 7(10):965-974. (Review).
109. Weisberger J., Emmons F., Gorczyca W. Cytochemical diagnosis of Gaucher's disease by iron stain. British Journal of Haematology 2004, 124(6):696.
110. Westbroek W., Gustafson A.M., Sidransky E. Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends in Molecular Medicine 2011, 17(9):485-493. (Research Support, N.I.H., Intramural Review).
111. Wilson J., Huynh C., Kennedy K.A., Ward D.M., Kaplan J., Aderem A., et al. Control of parasitophorous vacuole expansion by LYST/Beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathogens 2008, 4(10):e1000179. (Research Support, N.I.H., Extramural).
112. Wraith J.E. Lysosomal disorders. Seminars in Neonatology 2002, 7(1):75-83. (Review).
113. Yu Z., Persson H.L., Eaton J.W., Brunk U.T. Intralysosomal iron: A major determinant of oxidant-induced cell death. Free Radical Biology & Medicine 2003, 34(10):1243-1252. (Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.).
114. Zhang Y., Mikhael M., Xu D., Li Y., Soe-Lin S., Ning B., et al. Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit. Antioxidants & Redox Signaling 2010, 13(7):999-1009. (Research Support, Non-U.S. Gov't).